Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Vicadrostat | C15H12ClN3O3 | CID 118676295 - PubChem
Vicadrostat | TargetMol
Vicadrostat | P450 (e.g. CYP17) inhibitor | CAS 1868065-21-7 | Selleck
Vicadrostat (BI 690517) | Aldosterone synthase inhibitor | Probechem ...
Vicadrostat « New Drug Approvals
化合物 Vicadrostat CAS#: 1868065-21-7
Urine Extracellular Vesicle miRNA Changes Induced by Vicadrostat with ...
Estudio de vicadrostat (BI 690517) y empagliflozina en personas con ...
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together ...
Cumulative Effects of Vicadrostat and Empagliflozin on Albuminuria in ...
Vicadrostat | Aldosterone Synthase Inhibitor | MedChemExpress
Cumulative Effects of Vicadrostat (BI 690517) and Empagliflozin on ...
Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in ...
Vicadrostat | 醛固酮合成酶抑制剂 | MCE
Vicadrostat - Drug Targets, Indications, Patents - Synapse
Vicadrostat | ≥99%(HPLC) | Selleck | P450 (e.g. CYP17) 阻害剤
Vicadrostat (BI 690517) | Aldosterone Synthase Inhibitor | MedChemExpress
Drastisk effekt: Jardiance i kombination med vicadrostat kan måske få ...
Vicadrostat (BI 690517) / empagliflozin | Boehringer Ingelheim
Vicadrostat | MedPath
A Study to Test Whether Vicadrostat in Combination With Empagliflozin ...
Pharmacodynamic effects of highly selective aldosterone synthase ...
WCN25-2620 CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR ...
The potential for improving cardio-renal outcomes in chronic kidney ...
Vicadrostat_化工百科
Bi 690517 – Application in Therapy and Current Clinical Research
D3 VICOTRAT Injektionslsg.z.intramusk.Anwend.Amp. 5X1 ml mit E-Rezept ...
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney ...
Frontiers | The selective aldosterone synthase inhibitor Baxdrostat ...
ERA25||Vicadrostat Effective Across KDIGO Risk Classes in CKD
Vicadrostat: A New CKD Treatment Approach | PDF | Chronic Kidney ...
#NephMadness 2025: Resistant Hypertension Region – AJKD Blog
(PDF) Phase 1 studies of the safety, tolerability, pharmacokinetics ...
Vicadrostat(Vicadrostat) - 药物靶点：ALDOS_在研适应症：慢性肾病，心脏衰竭，糖尿病_专利_临床_研发
Vicadrostat: Uses, Interactions, Mechanism of Action | DrugBank
vicadrostat-药品详情-NextPharma®数据库-ByDrug-医药魔方数据库
Vicadrostat-Empagliflozin Combination Reduces Albuminuria in Chronic ...
University of California Health Heart Failure Trial → Test Whether ...
新药前沿｜难治性高血压患者有望迎来新一代药物Baxdrostat！医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Frontiers | The potential roles of JAK/STAT signaling in the ...
Synthesis of Carbon‐13 and Carbon‐14 Labeled BI 690517 (Vicadrostat ...
Article - Urine Extracellular Vesicle miRNA Changes Induced by ...
Visual Abstracts - World Congress of Nephrology 2025
Vicadrostat(Vicadrostat) - 药物靶点：CYP11B2_在研适应症：2型糖尿病，高血压，慢性肾病_专利_临床_研发
Clinical Properties and Non-Clinical Testing of Mineralocorticoid ...
The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and ...
ACC2023｜张英：评估Baxdrostat在未控制的高血压患者中的疗效和安全性—HALO试验解读 -- 严道医声网
Triazole Antifungal Mechanism Of Action
Camp Signal Pathway : Subcellular Organization of the cAMP Signaling ...
New Therapies for the Management of Chronic Kidney Disease - PMC
Baxdrostat: A Next-Generation Aldosterone Synthase Inhibitor Offering ...
Universitätsklinikum Würzburg: easikidney
Randomized, Placebo-Controlled Trial on the Renal and Systemic ...
Advance-HTN: Return of the systolic order – Lorundrostat’s role in ...
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant ...
Revising the Roles of Aldosterone in Vascular Physiology and ...
Empawood (Empagliflozin Tablet ) | CPHI Online
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD ...
Aldosterone Synthase Inhibitors Market Forecast, 2026-2033
(PDF) Evaluating phase II results of Baxdrostat, an aldosterone ...
Baxdrostat (CIN-107) | CAS 1428652-17-8 | AbMole BioScience ...
